Skip to main content
OpenTrials

Clinical trial condition

Hematologic Diseases

Explore clinical trials studying Hematologic Diseases. Study availability and eligibility vary by location and protocol.

15,344 public trials 2,835 recruiting studies
Refine in advanced search Browse all conditions

Hematologic Diseases trial results

Recruiting

Study to Evaluate the Safety and Tolerability of EP0042

NCT04581512

Conditions
Acute Myeloid Leukemia, Bone Marrow Diseases, Chronic Disease, +14 more
Locations
  • Royal Perth Hospital Perth, Western Australia, Australia
  • Amsterdam UMC Amsterdam, Netherlands
  • Erasmus MC Rotterdam, Netherlands
  • The Royal Marsden London, UK, United Kingdom
View Trial Details
Recruiting

A Study of DZD8586 Combination in CLL/SLL (TAI-SHAN10)

NCT07154264

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Disease Attributes, +14 more
Locations
  • Anhui Provincial Cancer Hospital Hefei, Anhui, China
  • Peking University Third Hospital Beijing, Beijing Municipality, China
  • Zhujiang Hospital of Southern Medical University Guangzhou, Guangdong, China
  • Nanfang Hospital, Southern Medical University Guangzhou, Guangdong, China
View all 15 locations
View Trial Details
Recruiting

A Study of Gilteritinib in Combination With Ivosidenib or Enasidenib in People With Acute Myeloid Leukemia (AML)

NCT05756777

Conditions
Acute Myeloid Leukemia (AML), Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations
  • Memorial Sloan Kettering Basking Ridge Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen Montvale, New Jersey, United States
  • Memorial Sloan Kettering Suffolk-Commack Commack, New York, United States
View Trial Details
Recruiting

A Study to Assess the Safety and Anti-Tumor Activity of REGN7945 in Combination With Linvoseltamab in Adult Participants With Relapsed/Refractory Multiple Myeloma

NCT06669247

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations
  • Royal Prince Alfred Hospital Sydney, New South Wales, Australia
  • Illawarra Cancer Care Centre Wollongong, New South Wales, Australia
  • Pindara Private Hospital Benowa, Queensland, Australia
  • Royal Adelaide Hospital Adelaide, South Australia, Australia
View Trial Details
Recruiting

Evaluation of Two Dose Levels of Quizartinib as Maintenance in FLT3-ITD (+) Acute Myeloid Leukemia Patients in Complete Remission

NCT06824168

Conditions
Acute Myeloid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations
  • John Hopkins School of Medicine Baltimore, Maryland, United States
  • Umass Memorial Health Care Systems Worcester, Massachusetts, United States
  • Roswell Park Cancer Institute Buffalo, New York, United States
  • Weill Cornell New York, United States
View all 58 locations
View Trial Details
Recruiting

TRANSPIRE: Lung Injury in a Longitudinal Cohort of Pediatric HSCT Patients

NCT04098445

Conditions
Blood Platelet Disorders, Bronchial Diseases, Bronchiolitis, +14 more
Locations
  • University of California San Francisco San Francisco, California, United States
  • Children's Hospital Colorado Aurora, Colorado, United States
  • Dana-Farber Cancer Institute/Boston Children's Hospital Boston, Massachusetts, United States
  • University of Minnesota Minneapolis, Minnesota, United States
View Trial Details
Recruiting

68Ga-BCMA PET/CT in Multiple Myeloma

NCT07319897

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Disease, +17 more
Locations
  • Beijing An Zhen Hospital of the Capital University of Medical Sciences Beijing, Beijing Municipality, China
  • Beijing Tsinghua Changgung Hospital Beijing, Beijing Municipality, China
  • Peking University First Hospital Beijing, Beijing Municipality, China
  • the Second Hospital of Hebei Medical University Shijiazhuang, Hebei, China
View Trial Details

Related conditions